Comparison of Regional Anaesthesia Methods for Femoral Neck Fracture Surgery
Comparison of the Effectiveness of Lumbar Plexus Block and Unilateral Spinal Anaesthesia in Patients Undergoing Femoral Neck Fracture Surgery
1 other identifier
interventional
300
1 country
1
Brief Summary
Femoral fracture surgery is frequently performed especially in geriatric population. Compared to general anaesthesia, regional anaesthesia is preferred to general anaesthesia in the geriatric patient population due to lower postoperative pulmonary complications, reduced frequency of delirium and analgesic requirement, intraoperative haemodynamic stability, early postoperative mobilisation and early discharge. Central and peripheral regional anaesthesia methods have advantages and disadvantages. This situation causes difficulties in the choice of anaesthesia method. Central regional anaesthesia techniques have more haemodynamic effects and higher frequency of complications compared to peripheral methods. The disadvantages of peripheral methods are that they require ultrasound, block needle, nerve stimulator and require knowledgeable and skilled practitioners. Since there is no study showing the comparison of peripheral nerve blocks and hypobaric spinal anaesthesia with objective nociception values and there are difficulties in the choice of anaesthesia method in this regard, a study was deemed necessary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2024
CompletedFirst Posted
Study publicly available on registry
January 25, 2024
CompletedStudy Start
First participant enrolled
January 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2025
CompletedNovember 18, 2025
November 1, 2025
1.2 years
January 16, 2024
November 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
intraoperative haemodynamic parameters
non-invasive systolic, diastolic and mean arterial pressure mean arterial pressure (mm/hg)
intraoperative 2 hours
Secondary Outcomes (4)
Entropy
intraoperative 2 hours
SPI
intraoperative 2 hours
sedation and analgesic
intraoperative 2 hours
Intraoperative bleeding
intraoperative 2 hours
Study Arms (3)
hypobaric spinal anaesthesia
ACTIVE COMPARATOR25 gauge quincke needle will be used for spinal anaesthesia. After the lateral position is given to the patient with the side to be operated on, the patient will be entered through the appropriate interval (L3-4 or L4-5) to apply hypobaric spinal anaesthesia, and after the feeling of falling in the subdural area is obtained, Cerebro Spinal Fluid arrival will be seen and the drug consisting of 0.5% Bupivacain and distilled water with bupivacaine hydrochloride active ingredient will be applied in the range of 2-4cc according to the patient's height and weight.
lumbar plexus block
ACTIVE COMPARATORA 10-15 cm peripheral block needle, ultrasound and nerve stimulator will be used for lumbar plexus block. Buvicaine with 0.5% Bupivacaine Hydrochloride active substance will be used. It will be diluted half and half with saline. It will be applied in accordance with the patient's height and weight, not exceeding 2mg/kg.
hyperbaric spinal anaesthesia
ACTIVE COMPARATOR25 gauge quincke needle will be used for spinal anaesthesia. After the lateral position is given to the patient with the side to be operated on, the patient will be entered through the appropriate interval (L3-4 or L4-5) to apply hypobaric spinal anaesthesia, and after the feeling of falling in the subdural area is obtained, Cerebro Spinal Fluid arrival will be seen and the drug consisting of 0.5% hyper Bupivacain hydrochloride active ingredient will be applied in the range of 2-4cc according to the patient's height and weight.
Interventions
0.5% Bupivacain and distilled water with bupivacaine hydrochloride active ingredient will be applied in the range of 2-4cc according to the patient's height and weight.
ultrasound and nerve stimulator will be used for lumbar plexus block
0.5% hyperbaric Bupivacain hydrochloride active ingredient will be applied in the range of 2-4cc according to the patient's height and weight.
Eligibility Criteria
You may qualify if:
- \>18 years and \<90 years
- ASA (American Society of Anesthesiologists) score between I and IV
- Patients who will undergo femoral neck fracture surgery
You may not qualify if:
- Previous local anesthetic allergy
- Those with bleeding diathesis disorder
- Having a mental disorder
- Those who are allergic to the drugs used
- Patients who did not consent to participate in the study
- Presence of infection in the block area
- Body mass index \>30
- Preoperative or intraoperative general anesthesia
- Patients for whom consent cannot be obtained
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bursa Yuksek Ihtisas Training and Research Hospital
Bursa, 16110, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 16, 2024
First Posted
January 25, 2024
Study Start
January 25, 2024
Primary Completion
April 1, 2025
Study Completion
April 13, 2025
Last Updated
November 18, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share